Next, 2.5 mg/kg azathioprine was administered to CML mice for a 14-day period, which markedly reduced the population of LSK cells (Lin-Sca-1+c-Kit+) from 3.09% to 2.01% (Figure 6E). The gene discussed is KIT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.